SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-012061
Filing Date
2024-08-13
Accepted
2024-08-13 16:20:31
Documents
74
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20240630x10q.htm   iXBRL 10-Q 1450700
2 EX-31.1 armp-20240630xex31d1.htm EX-31.1 15790
3 EX-31.2 armp-20240630xex31d2.htm EX-31.2 15288
4 EX-32.1 armp-20240630xex32d1.htm EX-32.1 8034
5 EX-32.2 armp-20240630xex32d2.htm EX-32.2 8217
6 GRAPHIC armp-20240630x10q001.jpg GRAPHIC 45714
  Complete submission text file 0001558370-24-012061.txt   6374311

Data Files

Seq Description Document Type Size
7 EX-101.SCH armp-20240630.xsd EX-101.SCH 43328
8 EX-101.CAL armp-20240630_cal.xml EX-101.CAL 50538
9 EX-101.DEF armp-20240630_def.xml EX-101.DEF 152144
10 EX-101.LAB armp-20240630_lab.xml EX-101.LAB 383234
11 EX-101.PRE armp-20240630_pre.xml EX-101.PRE 289644
77 EXTRACTED XBRL INSTANCE DOCUMENT armp-20240630x10q_htm.xml XML 1052931
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 241201834
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)